Key result
Persistent AF recurrence after ablation is linked to ~5.5-fold higher HF hospitalization risk in reduced LVEF.
Its licence doesn't allow us to show a copy here.
Why the study?
Is evolving postablation atrial fibrillation recurrence pattern (paroxysmal vs. persistent) associated with subsequent heart failure hospitalization in patients with baseline left ventricular systolic dysfunction (LVEF <50%)?
Cohort (n=381)
No
Is evolving postablation atrial fibrillation recurrence pattern (paroxysmal vs. persistent) associated with subsequent heart failure hospitalization in patients with baseline left ventricular systolic dysfunction (LVEF <50%)?
Among patients with LV systolic dysfunction undergoing AF ablation, both paroxysmal and persistent AF recurrences significantly increase the risk of subsequent HF hospitalization, with persistent recurrence conferring over a five-fold risk that warrants closer surveillance and rhythm-control reassessment.
Monitoring evolving postablation recurrence may aid HF risk assessment in AF with LV dysfunction; leaves open prospective validation.
Catheter ablation improves outcomes in patients with atrial fibrillation (AF) and left ventricular (LV) systolic dysfunction, but the prognostic significance of postablation recurrence pattern and its evolution remains unclear. We investigated whether evolving postablation recurrence pattern was associated with subsequent heart failure (HF) hospitalization. This retrospective single-center study included 381 of 5535 consecutive patients who underwent first-time AF ablation between 2012 and 2024 and had baseline left ventricular ejection fraction (LVEF) <50%. Recurrence was defined as any atrial tachyarrhythmia lasting >30 s beyond the 3-month blanking period and classified as paroxysmal or persistent (lasting >7 days). Recurrence pattern was modeled as a time-dependent variable and updated upon documentation of paroxysmal or persistent recurrence during follow-up. During a median follow-up of 49 months, 140 patients experienced recurrence (71 paroxysmal only and 69 persistent, including 21 who progressed from paroxysmal to persistent recurrence) and 61 experienced HF hospitalization. In a multivariable time-dependent Cox model adjusted for age, sex, baseline LVEF, prior myocardial infarction, prior HF hospitalization, and baseline AF type, both paroxysmal recurrence [hazard ratio (HR), 2.38; 95% confidence interval (CI), 1.15-4.90; p = 0.019] and persistent recurrence (HR, 5.45; 95% CI, 2.59-11.46; p < 0.001) were associated with HF hospitalization compared with no recurrence. Persistent recurrence was also associated with a higher risk than paroxysmal recurrence (HR, 2.29; 95% CI, 1.00-5.25; p = 0.049). Time-updated assessment of postablation AF recurrence pattern revealed differential risks of subsequent HF hospitalization among patients with LV systolic dysfunction. Both paroxysmal and persistent recurrence were associated with HF hospitalization, with persistent recurrence representing a particularly high-risk state that may warrant closer HF surveillance and reassessment of rhythm-control strategies.
No takes yet. Share an insight, caveat, or question.
Okada et al. (2026) conducted a cohort in Atrial fibrillation and left ventricular systolic dysfunction (LVEF <50%) (n=381). Postablation atrial fibrillation recurrence (persistent and paroxysmal) vs. No postablation atrial fibrillation recurrence was evaluated on Subsequent heart failure hospitalization (HR 5.45, 95% CI 2.59-11.46, p=< 0.001). Postablation persistent (HR 5.45; 95% CI 2.59-11.46; p<0.001) and paroxysmal AF recurrence (HR 2.38; 95% CI 1.15-4.90; p=0.019) increased HF hospitalization risk vs no recurrence in LVEF <50%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: